|
This is an index of adverse event reports related to Hepsera (Adefovir Dipivoxil). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (151)
Cases resulting in a serious event (151)
Cases resulting in death (12)
Cases resulting in life threatening events (8)
Cases resulting in hospitalization (44)
Cases resulting in disability (3)
Cases resulting in other serious reactions (91)
Below is a sample of adverse event reports reports related to Hepsera (Adefovir Dipivoxil). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in 34 year old female receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-31
Patient: 34 year old female
Adverse reactions / side effects: Abortion Induced
Suspect drug(s):
Hepsera
Administration route: Oral
Indication: Hepatitis B
Start date: 2006-09-28
Lamivudine
Administration route: Oral
Indication: Hepatitis B
Start date: 2006-11-01
Adverse event in 34 year old female receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-31
Patient: 34 year old female
Adverse reactions / side effects: Abortion Induced
Suspect drug(s):
Hepsera
Administration route: Oral
Indication: Hepatitis B
Start date: 2006-09-28
Lamivudine
Administration route: Oral
Indication: Hepatitis B
Start date: 2006-11-01
Adverse event in male receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-31
Patient: male
Adverse reactions / side effects: Hepatic Neoplasm Malignant
Suspect drug(s):
Hepsera
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2006-02-13
Zefix
Administration route: Oral
Indication: Chronic Hepatitis
Start date: 2005-02-21
Zefix
Adverse event in male receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-29
Patient: male
Adverse reactions / side effects: Hepatic Neoplasm Malignant
Suspect drug(s):
Hepsera
Administration route: Oral
Start date: 2004-01-08
Zefix
Administration route: Oral
Start date: 1998-02-04
Adverse event in male receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-26
Patient: male
Adverse reactions / side effects: Hepatic Neoplasm Malignant
Suspect drug(s):
Hepsera
Administration route: Oral
Start date: 2005-01-07
Zefix
Administration route: Oral
Start date: 2003-08-29
Adverse event in male receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-26
Patient: male
Adverse reactions / side effects: Hepatic Neoplasm Malignant
Suspect drug(s):
Hepsera
Administration route: Oral
Start date: 2006-01-01
Hepsera
Administration route: Oral
Start date: 2004-04-09
End date: 2006-01-01
Zefix
Administration route: Oral
Start date: 2000-02-17
Adverse event in 50 year old male receiving Hepsera (Adefovir Dipivoxil)
Reported by a physician from Korea, Republic of on 2007-10-26
Patient: 50 year old male
Adverse reactions / side effects: Hepatic Neoplasm Malignant, Lung Cancer Metastatic, Melaena, Abdominal Pain Upper
Adverse event resulted in: death
Suspect drug(s):
Hepsera (Adefovir Dipivoxil)
Adverse event in 30 year old female receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-25
Patient: 30 year old female
Adverse reactions / side effects: Hepatic Steatosis
Suspect drug(s):
Hepsera (Adefovir Dipivoxil)
Adverse event in male receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-25
Patient: male
Adverse reactions / side effects: Hepatic Neoplasm Malignant
Suspect drug(s):
Hepsera
Administration route: Oral
Start date: 2005-12-08
Zefix
Administration route: Oral
Start date: 2003-08-20
Adverse event in female receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-25
Patient: female
Adverse reactions / side effects: Hepatic Neoplasm Malignant
Suspect drug(s):
Hepsera
Administration route: Oral
Indication: Chronic Hepatitis
Start date: 2004-03-08
Zefix
Administration route: Oral
Indication: Chronic Hepatitis
Start date: 2000-01-26
Adverse event in female receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-25
Patient: female
Adverse reactions / side effects: Hepatic Neoplasm Malignant
Suspect drug(s):
Hepsera
Administration route: Oral
Start date: 2005-07-25
Zefix
Start date: 2004-08-17
Adverse event in male receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-24
Patient: male
Adverse reactions / side effects: Hepatic Neoplasm Malignant
Suspect drug(s):
Hepsera
Administration route: Oral
Start date: 2003-10-24
Zefix
Administration route: Oral
Start date: 2002-10-07
Adverse event in male receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-24
Patient: male
Adverse reactions / side effects: Hepatic Neoplasm Malignant
Suspect drug(s):
Hepsera
Administration route: Oral
Indication: Chronic Hepatitis
Start date: 2004-02-23
Zefix
Administration route: Oral
Indication: Chronic Hepatitis
Start date: 2001-02-19
Adverse event in male receiving Hepsera (Adefovir Dipivoxil)
Reported by a physician from Germany on 2007-10-24
Patient: male
Adverse reactions / side effects: Rhabdomyolysis
Suspect drug(s):
Hepsera (Adefovir Dipivoxil)
Other drugs received by patient: Fenofibrate
Adverse event in male receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-24
Patient: male
Adverse reactions / side effects: Hepatic Neoplasm Malignant
Suspect drug(s):
Hepsera
Administration route: Oral
Start date: 2003-03-11
Zefix
Start date: 2001-01-29
Other drugs received by patient: Interferon
Adverse event in male receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-24
Patient: male
Adverse reactions / side effects: Hepatic Neoplasm Malignant
Adverse event resulted in: death
Suspect drug(s):
Hepsera
Administration route: Oral
Start date: 2004-01-16
End date: 2006-07-24
Zefix
Administration route: Oral
Start date: 2001-06-06
End date: 2006-07-24
Adverse event in male receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-23
Patient: male
Adverse reactions / side effects: Hepatic Neoplasm Malignant
Suspect drug(s):
Hepsera
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2006-02-13
Zefix
Administration route: Oral
Indication: Chronic Hepatitis
Start date: 2005-02-21
Zefix
Adverse event in 34 year old female receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-23
Patient: 34 year old female
Adverse reactions / side effects: Abortion Induced
Suspect drug(s):
Hepsera
Administration route: Oral
Indication: Hepatitis B
Start date: 2006-09-28
Lamivudine
Administration route: Oral
Indication: Hepatitis B
Start date: 2006-11-01
Adverse event in male receiving Hepsera (Adefovir Dipivoxil)
Reported by a individual with unspecified qualification from Australia on 2007-10-22
Patient: male
Adverse reactions / side effects: Hepatitis
Adverse event resulted in: death
Suspect drug(s):
Epivir
Administration route: Oral
Indication: Hepatitis B
Hepsera
Administration route: Oral
Indication: Hepatitis B
Adverse event in male receiving Hepsera (Adefovir Dipivoxil)
Reported by a physician from United Kingdom on 2007-10-22
Patient: male
Adverse reactions / side effects: Haemolytic Anaemia, Thrombocytopenia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Hepsera (Adefovir Dipivoxil)
Other drugs received by patient: Tacrolimus
Adverse event in 57 year old male receiving Hepsera (Adefovir Dipivoxil)
Reported by a individual with unspecified qualification from Australia on 2007-10-19
Patient: 57 year old male
Adverse reactions / side effects: Drug Resistance, HBV DNA Increased
Suspect drug(s):
Hepsera (Adefovir Dipivoxil)
Other drugs received by patient: Lamivudine; Lamivudine; Lamivudine
Adverse event in male receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-18
Patient: male
Adverse reactions / side effects: Hepatic Neoplasm Malignant
Suspect drug(s):
Hepsera
Administration route: Oral
Start date: 2004-01-08
Zefix
Administration route: Oral
Start date: 1998-02-04
Adverse event in male receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-18
Patient: male
Adverse reactions / side effects: Hepatic Neoplasm Malignant
Suspect drug(s):
Hepsera
Administration route: Oral
Start date: 2003-03-11
Zefix
Start date: 2001-01-29
Adverse event in male receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-18
Patient: male
Adverse reactions / side effects: Hepatic Neoplasm Malignant
Suspect drug(s):
Hepsera
Administration route: Oral
Start date: 2003-10-24
Zefix
Administration route: Oral
Start date: 2002-10-07
Adverse event in male receiving Hepsera (Adefovir Dipivoxil)
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-17
Patient: male
Adverse reactions / side effects: Hepatic Neoplasm Malignant
Suspect drug(s):
Hepsera
Administration route: Oral
Indication: Chronic Hepatitis
Start date: 2004-02-23
Zefix
Administration route: Oral
Indication: Chronic Hepatitis
Start date: 2001-02-19
|
